Can B Corp (NASC) stock: key figures, P/E, revenue and dividend
Industrials · United States
Price
0.01 USD
Market cap
992,383.30 USD
P/E (2024)
–
P/S (2024)
–
Dividend yield
0.00 %
Net margin
–
Return on equity (ROE)
–
Return on assets (ROA)
–
Can B Corp financials
| Fiscal year | 2023 |
|---|---|
| Revenue | 2.16 m USD |
| Gross profit | 358,698.00 USD |
| Operating income | -7.49 m USD |
| EBIT | -7.22 m USD |
| Net income | -9.74 m USD |
| Diluted EPS – continuing operations | -0.77 USD |
Full history since 2014, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About Can B Corp
Nascent Pharma Holdings, Inc. engages in the protection and commercialization of cannabis patents. It produces superfood drink mix products under the Longevity brand name. The company was formerly known as Can B Corp. and changed its name to Nascent Pharma Holdings, Inc. in September 2025. Nascent Pharma Holdings, Inc. was incorporated in 2005 and is based in Hicksville, New York.
More stocks
- Appsoft Technologies, Inc. (ASFT)
- GeoVax Labs, Inc. (GOVX)
- JRSIS HEALTH CARE Corp (JRSS)
- POWERCOMPUTE, INC. (PWCM)
- Vocodia Holdings Corp (VHAI)
- DarkPulse, Inc. (DPLS)
- Onar Holding Corp (ONAR)
- Kairos Pharma, LTD. (KAPA)
- VOLITIONRX LTD (VNRX)
- B-Scada, Inc. (SCDA)
- Hubilu Venture Corp (HBUV)
- AXIM BIOTECHNOLOGIES, INC. (AXIM)
Not investment advice. All data without warranty, price as of 13.11.2026. Details in the risk notice.